Clinical Trial Update: pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial update for a pDNA intralesional cancer vaccine in cutaneous melanoma (Stage III/IV) with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Drugs mentioned

• pDNA intralesional cancer vaccine

Snippet

Sponsor: TuHURA Biosciences, Inc. | Conditions: Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2022-08-08